Trial Site Detail
Drug: |
Imatinib + Atezolizumab |
|||
|---|---|---|---|---|
Trial: |
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments (ATEZOGIST) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
Chru Tours |
Principal Investigator: |
|
|---|---|
Contact: |
Thierry Lecomte 02 47 47 47 47 thierry.lecomte@med.univ-tours.fr |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Chru Tours Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.